Recombinant Myostatin: Isolation and Use in Vaccines
https://doi.org/10.33647/2074-5982-19-3-17-22
Abstract
Protein myostatin is not only a potential target for therapeutic effects in pathologies of the muscular system, but also a tool for biotechnological regulation of the meat productivity of farm animals. The action of myostatin can be blocked by inducing autoantibody synthesis using recombinant myostatin (rMST) as an antigen. E. coli producer strain Bl21/pET28-MSTN was obtained with a high level of recombinant protein expression in inclusion bodies. Purified rMST was used to immunize sheep and rabbits. Using the created ELISA test system for the detection of antibodies to myostatin in the blood of sheep, it was shown that rMST is immunogenic (the working titer of sera is 1/400–1/800). As a result of vaccination of rabbits over a monthly period, the average body weight and average daily weight gain in animals of the experimental groups was observed to increase compared to the control group.
About the Authors
E. M. KoloskovaRussian Federation
Elena M. Koloskova, Cand. Sci. (Biol.)
249013, Kaluga Region, Borovsk, Institute Village
V. A. Ezerskiy
Russian Federation
Vadim A. Ezerskiy
249013, Kaluga Region, Borovsk, Institute Village
References
1. Колоскова Е.М., Езерский В.А., Жукова О.Б. Получение бактериального рекомбинантного миостатина для индуцирования синтеза специфических к миостатину аутоантител. Биомедицина. 2022;18(3):22–26. [Koloskova E.M., Ezerskiy V.A., Zhukova O.B. Poluchenie bakterial'nogo rekombinantnogo miostatina dlya indutsirovaniya sinteza spetsificheskikh k miostatinu autoantitel [Preparation of bacterial recombinant myostatin to induce the synthesis of myostatin-specific autoantibodies]. Biomeditsina [Journal Biomed]. 2022;18(3):22–26. (In Russian)]. DOI: 10.33647/2074-5982-18-3-22-26.
2. Колоскова Е.М., Езерский В.А., Жукова О.Б. На пути к разработке биоинженерных методов повышения мясной продуктивности животных: получение бактериального штамма-продуцента рекомбинантного миостатина. Проблемы биологии продуктивных животных. 2022;4:49–60. [Koloskova E.M., Ezerskiy V.A., Zhukova O.B. Na puti k razrabotke bioinzhenernykh metodov povysheniya myasnoy produktivnosti zhivotnykh: poluchenie bakterial'nogo shtamma-produtsenta rekombinantnogo miostatina [Towards the development of bioengineering methods to enhance meat productivity of animals: Constructing a bacterial strain producing recombinant myostatin]. Problemy biologii produktivnykh zhivotnykh [Problems of Productive Animal Biology]. 2022;4:49–60. (In Russian)].
3. Baneyx F., Mujacic M. Recombinant protein folding and misfolding in Escherichia coli. Nat. Biotechnol. 2004;22(11):1399–1408. DOI: 10.1038/nbt1029.
4. Chen M.M., Zhao Y.P., Zhao Y., Deng S.L., Yu K. Regulation of myostatin on the growth and development of skeletal muscle. Front. Cell. Dev. Biol. 2021;9:785712. DOI: 10.3389/fcell.2021.785712.
5. Makrides S.C. Strategies for achieving high-level expression of genes in Escherichia coli. Microbiol. Rev. 1996;60(3):512–538. DOI: 10.1128/mr.60.3.512-538.1996.
6. Nielsen T.L., Vissing J., Krag T.O. Antimyostatin treatment in health and disease: The story of great expectations and limited success. Cells. 2021;10(3):533. DOI: 10.3390/cells10030533.
7. Xu Y., Mao L., Zheng Y. Prokaryotic expression and immunogenicity analysis of yak recombinant myostatin. Anim. Biotechnol. 2012;23(4):253–260. DOI: 10.1080/1 0495398.2012.722157.
Review
For citations:
Koloskova E.M., Ezerskiy V.A. Recombinant Myostatin: Isolation and Use in Vaccines. Journal Biomed. 2023;19(3):17-22. (In Russ.) https://doi.org/10.33647/2074-5982-19-3-17-22